Precision Biosciences: Smith trust sells 7,056 shares

The notice identifies the shares as founder shares acquired from the issuer as compensation on January 26, 2006, and links the sale to a charitable remainder unitrust.

Available on EDGAR 11/05/2026 - 04:16 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Precision Biosciences (DTIL) reported a Form 144 notice listing 7,056 common shares for sale, with an aggregate market value of $72,411.93 and an approximate sale date of November 5, 2026. The remarks state that the sale took place that day in the Jeff & Kristen Smith Charitable Remainder Unitrust account, where officer Jefferson J. Smith is a trustee and account stakeholder. The shares are identified as founder shares acquired from the issuer as compensation on January 26, 2006.

Key Figures

Shares listed for sale: 7,056 common shares Aggregate market value: $72,411.93 Shares outstanding: 27,935,719 shares

3 metrics

Shares listed for sale 7,056 common shares Approximate sale date: November 5, 2026

Aggregate market value $72,411.93 Value listed for the 7,056 common shares

Shares outstanding 27,935,719 shares Number listed in the sale information

Key Terms

Rule 144, Charitable Remainder Unitrust, attorney-in-fact

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Charitable Remainder Unitrust financial

"Jeff & Kristen Smith Charitable Remainder Unitrust account"

attorney-in-fact regulatory

"as attorney-in-fact for James Jefferson Smith"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DTIL shares did Jefferson J. Smith report for sale?

The notice lists 7,056 common shares for sale, with an aggregate market value of $72,411.93. Its remarks state that the sale took place that day in the Jeff & Kristen Smith Charitable Remainder Unitrust account, where Jefferson J. Smith is a trustee and account stakeholder.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001770169
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	SMITH J. JEFFERSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7056	72411.93	27935719	11/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/26/2006	Founder Shares	Issuer			7056	01/26/2006	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The sale today took place in the Jeff & Kristen Smith Charitable Remainder Unitrust account in which Jefferson J. Smith is a trustee and account stakeholder.
Date of Notice	11/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for James Jefferson Smith
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)